**Question:** Which is not seen in polycythemia vera?

**Core Concept:** Polycythemia vera is a chronic myeloproliferative disorder characterized by the overproduction of red blood cells, leading to increased viscosity and potential complications.

**Why the Correct Answer is Right:** Polycythemia vera is associated with the clonal proliferation of myelopoeitic stem cells (MPSCs) due to the activation of the Janus kinase 2 (JAK2) pathway, leading to uncontrolled erythropoiesis. This results in increased red blood cell mass and viscosity, which can lead to complications like stroke, heart attack, and phlebothrombosis.

**Why Each Wrong Option is Incorrect:**

A. **Option A:** Phlebothrombosis is a complication seen in polycythemia vera due to increased blood viscosity.
B. **Option B:** Hyperviscosity is a characteristic feature of polycythemia vera, caused by increased red blood cell mass.
C. **Option C:** Hypercoagulability is a feature seen in polycythemia vera due to increased blood viscosity and prothrombotic state.
D. **Option D:** The correct answer is not mentioned, as it is not a complication or feature of polycythemia vera.

**Clinical Pearl / High-Yield Fact:** Polycythemia vera is a chronic myeloproliferative disorder with characteristic features like increased red blood cell mass, hyperviscosity, and thrombosis. However, the correct answer (not mentioned) is not a complication or feature of polycythemia vera.

**Correct Answer:** The correct answer, which is not mentioned, is not seen in polycythemia vera.